Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Take-Two is closing two game studios under their Private Division label, with Kerbal Space Program 2 developer Intercept Games shutting down (as we already knew) and OlliOlli and Rollerdrome studio ...

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

There were six violations of a restricted airspace over Bedminster, New Jersey, while President Donald Trump was staying at his residence there over the weekend, the U.S. Air Force said. One of those ...

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

F-16 jets were among those dispatched to meet the Russian aircraft. LONDON -- Fighters from the North American Aerospace Defense Command (NORAD) on Sunday intercepted a Russian aircraft in the Alaskan ...

The Intercept welcomes back Maia Hibbett, who is returning to the publication as managing editor. In this position, Hibbett will shape The Intercept’s distinctive coverage and oversee newsroom ...

The U.S. military scrambled fighter jets Saturday to intercept three civilian planes flying near President Trump's Mar-a-Lago estate in Palm Beach, Florida, according to the North American Aerospace ...

Feb 20 - Artificial intelligence giant OpenAI lost a bid on Thursday to dismiss a lawsuit in New York federal court alleging it misused news articles published by The Intercept to train its popular ...